Tom Schilling

Tom Schilling

Auto-generated profile, based on publicly available information

Tom Schilling

Institute of Physiology, Humboldt University, Tucholskystr. 2, D-10117 Berlin, Germany

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
MDMichael Daniels
Michael Daniels
JRJack Rivers-Auty
Jack Rivers-Auty
TSTom Schilling
Tom Schilling
NSNicholas G. Spencer
Nicholas G. Spencer
WWWilliam Watremez
William Watremez
DBDavid Brough
David Brough
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase-1 (COX-1) and COX-2 enzymes. The NLRP3 inflammasome is a multi-protein complex responsible for the processing of the proinflammatory cytokine interleukin-1β and is implicated in many inflammatory diseases. Here we show that several clinically approved and widely used NSAIDs of the fenamate class are effective and selective inhibitors of the NLRP3 inflammasome via inhibition of the volume-regulated anion channel in macrophages, independently of COX enzymes. Flufenamic acid and mefenamic acid are efficacious in NLRP3-dependent rodent models of inflammation in air pouch and peritoneum. We also show therapeutic effects of fenamates using a model of amyloid beta induced memory loss and a transgenic mouse model of Alzheimer’s disease. These data suggest that fenamate NSAIDs could be repurposed as NLRP3 inflammasome inhibitors and Alzheimer’s disease therapeutics.

1 March 2004 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
TSTom Schilling
Tom Schilling
CSChristian Stock
Christian Stock
ASAlbrecht Schwab
Albrecht Schwab
CEClaudia Eder
Claudia Eder


1 August 2001 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
TSTom Schilling
Tom Schilling
RNRobert Nitsch
Robert Nitsch
UHUwe Heinemann
Uwe Heinemann
DHDorit Haas
Dorit Haas
CEClaudia Eder
Claudia Eder

1 November 2017 in Cell Chemical Biology
Verified
Journal Article
Open access
ABAlex G. Baldwin
Alex G. Baldwin
JRJack Rivers-Auty
Jack Rivers-Auty
MDMichael J.D. Daniels
Michael J.D. Daniels
CWClaire S. White
Claire S. White
CSCarl H. Schwalbe
Carl H. Schwalbe
DBDavid Brough
David Brough
NLRP3 is a receptor important for host responses to infection, yet is also known to contribute to devastating diseases such as Alzheimer's disease, diabetes, atherosclerosis, and others, making inhibitors for NLRP3 sought after. One of the inhibitors currently in use is 2-aminoethoxy diphenylborinate (2APB). Unfortunately, in addition to inhibiting NLRP3, 2APB also displays non-selective effects on cellular Ca2+ homeostasis. Here, we use 2APB as a chemical scaffold to build a series of inhibitors, the NBC series, which inhibit the NLRP3 inflammasome in vitro and in vivo without affecting Ca2+ homeostasis. The core chemical insight of this work is that the oxazaborine ring is a critical feature of the NBC series, and the main biological insight the use of NBC inhibitors led to was that NLRP3 inflammasome activation was independent of Ca2+. The NBC compounds represent useful tools to dissect NLRP3 function, and may lead to oxazaborine ring-containing therapeutics.

1 January 2014 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
TSTom Schilling
Tom Schilling
FMFrancesc Miralles
Francesc Miralles
CEClaudia Eder
Claudia Eder
Ion channels play pivotal roles in regulating important functions of macrophages, such as cytokine and chemokine production, migration, proliferation, phagocytosis and others. In this study, we have identified the transient receptor potential cation channel, subfamily M, member 7 (TRPM7) for the first time in macrophages. TRPM7 activity is differentially regulated in macrophages, i.e. current density in TRPM7 is significantly larger in anti-inflammatory M2-type macrophages than in untreated and in pro-inflammatory M1-type macrophages, whereas mRNA levels of TRPM7 remain unchanged upon cell polarisation. The specific TRPM7 inhibitors NS8593 and FTY720 abolish proliferation of macrophages induced by interleukin-4 (IL-4) and macrophage colony-stimulating factor (M-CSF), respectively, whereas proliferation arrest was not accompanied by induction of apoptosis or necrosis in macrophages. Furthermore, NS8593 and FTY720 prevented polarisation of macrophages towards the anti-inflammatory M2 phenotype. Inhibition of TRPM7 reduced IL-4-induced upregulation of arginase-1 (Arg1) mRNA levels and Arg1 activity, and abolished the inhibitory effects of IL-4 or M-CSF on LPS-induced TNF-α production by macrophages. In summary, our data suggest a main role of TRPM7 in the regulation of macrophage proliferation and polarisation.